Recap: Paratek Pharmaceuticals Q1 Earnings

Paratek Pharmaceuticals PRTK reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Paratek Pharmaceuticals missed estimated earnings by 6.06%, reporting an EPS of $-0.35 versus an estimate of $-0.33.

Revenue was up $6.38 million from the same period last year.

Last quarter the company missed on EPS by $0.22 which was followed by a 4.05% increase in the share price the next day.

Here's a look at Paratek Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.09	-0.29	-0.34	-0.35
EPS Actual	-0.13	-0.38	-0.33	-0.35
Revenue Estimate	63.45M	34.19M	29.17M	27.15M
Revenue Actual	75.60M	30.21M	29.64M	24.86M

To track all earnings releases for Paratek Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.